Federal Supply Schedule GS24F1283C

Award Date 2/15/95
Last Date to Order 9/29/09
Funding Federal Agency
Not listed
Contracting Federal Agency
Federal Acquisition Service
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, has been awarded multiple federal contracts and task orders by various civilian agencies including the Department of Veterans Affairs (VA), Department of Health and Human Services, and Department of Agriculture. The contracts, established under Roche's General Services Administration (GSA) Multiple Award Schedule (MAS) contracts, provide agencies with a...
Roche Diagnostics Corporation was awarded a multiple-award Federal Supply Schedule (FSS) contract by the U.S. Department of Veterans Affairs (VA) for in vitro diagnostics, reagents, and test kits. The 5-year contract, valued at up to $32.5 million, allows the VA and other federal agencies to acquire a wide range of Roche's medical equipment, laboratory instruments, and associated consumables on an as-needed basis. Under this FSS contract, Roche has received numerous delivery orders and blanket...
Roche Diabetes Care Inc. holds a General Services Administration (GSA) Federal Supply Schedule (FSS) contract for in-vitro diagnostics, reagents, and test kits, contract number V797D-50597, with a total potential value of $325,070,750. The contract is a multiple-award vehicle awarded to Roche, a leading manufacturer of diabetes management products, to provide a wide range of diabetic testing supplies to federal agencies, particularly the Indian Health Service (IHS) and the Department of...
This Blanket Purchase Agreement (BPA) with Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, provides the Department of Veterans Affairs (VA) with laboratory instruments, reagents, test kits, and associated products and services. The 5-year BPA, valued at over $7 million, was awarded by the VA's Veterans Integrated Service Network 2 to supply chemistry and immunochemistry laboratory testing capabilities at VA hospitals in the Bronx, New York area. Roche Diagnostics, a...
Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, has been awarded a Blanket Purchase Agreement (BPA) by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to provide in vitro diagnostics, reagents, and test supplies under the General Services Administration (GSA) Federal Supply Schedule 65-VII. The 5-year master BPA, with a ceiling value of $217,396.88, establishes a streamlined ordering mechanism for the VA's Veterans Integrated Service...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics. The $487,747.35 BPA contract, issued under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III), will provide the VA with critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. The contract supports the provision of...
The Department of Veterans Affairs (VA), through the Veterans Integrated Service Network 20 (VISN 20), awarded Roche Diagnostics Corporation a Blanket Purchase Agreement (BPA) to provide chemistry analyzers and associated laboratory equipment, reagents, and services. The BPA was awarded under Roche's General Services Administration (GSA) Schedule 66-III contract for critical laboratory analyzers, with a total ceiling value of $397,419.19 and an ultimate completion date of June 30, 2024. Roche...
The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA, valued at $1,041,901.25, allows the VA network to acquire CPRR microbiology reagents from Roche on an as-needed basis over the contract's term through September...
The Department of Veterans Affairs Veterans Health Administration (VA VHA) has awarded Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, a Blanket Purchase Agreement (BPA) under the General Services Administration (GSA) Schedule 65-VII for Invitro Diagnostics, Reagents, and Test Kits. The BPA has a period of performance from April 1, 2024 to March 31, 2029 with a potential value of $250,000.00. Through this IDV contract, the VA VHA will acquire WTX COAGUCHEK CPT WAIVED...
This series of Blanket Purchase Agreement (BPA) awards to Roche Diagnostics Corporation provide the U.S. Department of Defense's Defense Health Agency (DHA) and Air Force Life Cycle Management Center (AFLCMC) with critical medical equipment, reagents, and consumables to support laboratory operations at military treatment facilities and the U.S. Air Force School of Aerospace Medicine (USAFSAM) Epidemiology Laboratory. The BPA awards, issued against Roche's existing General Services Administration...
  • GS24F1283C
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements
  • 692
    Federal Contract Awards

Roche Diagnostics Corporation holds a federal supply schedule contract (GS24F1283C) with the General Services Administration (GSA) to provide a wide range of laboratory instruments, equipment, reagents, and associated products and services to U.S. federal agencies. Through this multiple award contract, Roche has received numerous delivery orders from civilian and defense agencies such as the Department of Veterans Affairs, Department of Defense, Department of Health and Human Services, and Indian Health Service to supply critical care analyzers, testing kits, sequencing equipment, and other medical/laboratory capabilities. Roche has also been awarded blanket purchase agreements by the VA and HHS to provide an ongoing supply of blood glucose monitors, reagents, and other consumables, demonstrating the company's established position as a prime vendor of in vitro diagnostic products and solutions to support federal healthcare operations. The contract has an original period of performance through September 2009, with Roche Diagnostics continuing to receive new task order awards to deliver specialized lab equipment, instruments, and services across the U.S.

Generated 10/2/24, 9:06 AM